Education
About Us
Working with TipRanks
Follow Us
Asia Green Biotechnology Corp. (TSE:ASIA)
:ASIA
RESEARCH TOOLSreports
ASIA Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$0.02 - C$0.02
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
C$543.71K
Enterprise ValueC$780.92K
Total Cash (Recent Filing)C$484.15K
Total Debt (Recent Filing)C$0.00
Price to Earnings (P/E)―
Beta1.02
Next Earnings
May 15, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding36,247,100
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Asia Green Biotechnology Corp. News
PremiumCompany Announcements
Asia Green Biotech Set to Acquire Waste Disposal Firm
PremiumCompany Announcements
Asia Green Biotech Completes Key Filings, CFO Resigns
PremiumCompany Announcements
Asia Green Faces Trading Restrictions Amid MCTOPremiumCompany Announcements
Asia Green Biotech Receives Trading OrderPremiumCompany Announcements
Asia Green Biotech Granted Trading Cease Order
PremiumCompany Announcements
Asia Green Biotech Reports Filing DelayPremiumCompany Announcements
Asia Green Biotech Faces Filing Delay
PremiumCompany Announcements
AGB Shifts Auditors and Exits Asian Markets---
ASIA FAQ
What was Asia Green Biotechnology Corp.’s price range in the past 12 months?
Asia Green Biotechnology Corp. lowest stock price was C$0.01 and its highest was C$0.01 in the past 12 months.
What is Asia Green Biotechnology Corp.’s market cap?
Asia Green Biotechnology Corp.’s market cap is C$543.71K.
When is Asia Green Biotechnology Corp.’s upcoming earnings report date?
Asia Green Biotechnology Corp.’s upcoming earnings report date is May 15, 2025 which is in 44 days.
How were Asia Green Biotechnology Corp.’s earnings last quarter?
Currently, no data Available
Is Asia Green Biotechnology Corp. overvalued?
According to Wall Street analysts Asia Green Biotechnology Corp.’s price is currently Overvalued.
Does Asia Green Biotechnology Corp. pay dividends?
Asia Green Biotechnology Corp. does not currently pay dividends.
What is Asia Green Biotechnology Corp.’s EPS estimate?
Asia Green Biotechnology Corp.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Asia Green Biotechnology Corp. have?
Asia Green Biotechnology Corp. has 36,247,100 shares outstanding.
What happened to Asia Green Biotechnology Corp.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Asia Green Biotechnology Corp.?
Currently, no hedge funds are holding shares in TSE:ASIA
---
Company Description
Asia Green Biotechnology Corp.
Asia Green Biotechnology Corp., an early stage international bio-technology company, focuses on the development, evaluation, testing, application, and supply of products derived from proprietary organic hybridization technology in Asia. The company focuses on planting, growing, and harvesting new and valuable strains of hemp and related crops. It has an agreement with Pathway Rx Inc. and PNW Biosciences Inc. for the clinical development and commercialization of the cannabis sativa varieties for prevention and treatment of COVID-19 and other infectious diseases. The company was formerly known as Asia Cannabis Corp. and changed its name to Asia Green Biotechnology Corp. in April 2020. Asia Green Biotechnology Corp. was incorporated in 2017 and is based in Calgary, Canada.
---
Technical Analysis
---